Both the TCGA analysis and microarray study showed that IDH-mutant/1p19q-codeleted gliomas had the highest level of SCG3 expression among the three subtypes of grade II/III gliomas (Figures 3A,B). This evidence concerns the gene SCG3 and central nervous system cancer.